Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.

Noelia Sanmamed,Lisa Joseph,Juanita Crook,Tim Craig,Padraig Warde,Anne Di Tomasso,Peter Chung,Alejandro Berlin,Andrew Bayley,Elantholi P Saibishkumar,Rachel Glicksman,Srinivas Raman,Charles Catton,Joelle Helou

Brachytherapy（2023）

引用 0|浏览48

暂无评分

摘要

LDR-BT was associated with higher biochemical and metastases control in our cohort when compared to moderately HF-EBRT. In the absence of a randomized trial, LDR-BT when feasible should be offered to patients with a life expectancy of >8 years.

查看译文

关键词

Brachytherapy,EBRT,Hypofractionation,LDR,Prostate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要